![](/img/cover-not-exists.png)
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma
Howard L Kaufman, Bret Taback, William Sherman, Dae Won Kim, William H Shingler, Dorota Moroziewicz, Gail DeRaffele, Josephine Mitcham, Miles W Carroll, Richard Harrop, Stuart Naylor, Seunghee Kim-SchVolume:
7
Language:
english
DOI:
10.1186/1479-5876-7-2
Date:
December, 2009
File:
PDF, 1.08 MB
english, 2009